Cargando…
Progestogens in menopausal hormone therapy
Progestogens share one common effect: the ability to convert proliferative endometrium to its secretory form. In contrast, their biological activity is varied, depending on the chemical structure, pharmacokinetics, receptor affinity and different potency of action. Progestogens are widely used in th...
Autores principales: | Bińkowska, Małgorzata, Woroń, Jarosław |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498031/ https://www.ncbi.nlm.nih.gov/pubmed/26327902 http://dx.doi.org/10.5114/pm.2015.52154 |
Ejemplares similares
-
Menopausal hormone therapy and venous thromboembolism
por: Bińkowska, Małgorzata
Publicado: (2014) -
Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings
por: Bińkowska, Małgorzata, et al.
Publicado: (2022) -
Progestogens as a component of menopausal hormone therapy: the right molecule makes the difference
por: Stevenson, John C, et al.
Publicado: (2020) -
Menopausal hormone therapy and breast cancer risk: All progestogens are not the same
por: Lambrinoudaki, Irene
Publicado: (2020) -
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
por: Deng, Yu, et al.
Publicado: (2022)